Our investigation demonstrated that disruption of JAK2‐STAT4 pathway by Xa contributed to its inhibitory effects on the expression of BARD1 and HR pathway in NSCLC cells (Figure 7). Here, BARD1 is linked to non-small cell lung carcinoma.